Denfotex Limited (03471320): administration
- Status
- Administration ended
- Administration began
- 2011-08-09
- Incorporated
- 1997-11-25
- Location
- Gloucester
- Industry
- 2442
Why it went into administration
- Cash flow / liquidity pressure
From the administrators' statement
Denfotex Light Systems Limited (“DLS”) and Denfotex Limited (“DFX”) are wholly owned subsidianes of Denfotex Technologies Limited (“DTL”)
DTL was incorporated to commercialise Photo Activated Disinfection (PAD), a technology for the treatment of human bactenal and fungal infections, initially researched and patented by the Eastman Dental Institute, University College London (UCL) In 2002 DTL was granted an exclusive licence by UCL for the treatment of canes and endodontic disease In collaboration with Carl Zeiss Meditec (CZM), and with a licence to use their opto-electronic technology, development was commenced at a facility, acquired in 2003 from CZM, In Inverkeithing, Scotland
DFX was formed tn 2003 by the management team to further develop PAD, a unique treatment to kill bacterial and fungal oral infections to avoid/reduce traditional dental surgery eg extraction and drilling Development of photosensitiser chemistry started at laboratones at Handcross near Crawley Manufacturing of dental surgery units and photosensitiser solutions started alongside a program of marketing initiatives, clinical trials, and continuing research and development to improve the CZM technology
Administrators' statement of proposals (2011-10-10) · Companies House register